
Christopher C. Caillouet
Examiner (ID: 8951, Phone: (571)270-3968 , Office: P/1745 )
| Most Active Art Unit | 1745 |
| Art Unit(s) | 1791, 1745 |
| Total Applications | 862 |
| Issued Applications | 546 |
| Pending Applications | 67 |
| Abandoned Applications | 259 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6132050
[patent_doc_number] => 20020077477
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-06-20
[patent_title] => 'Catalyst for the production of olefin polymers'
[patent_app_type] => new
[patent_app_number] => 10/042797
[patent_app_country] => US
[patent_app_date] => 2002-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3129
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20020077477.pdf
[firstpage_image] =>[orig_patent_app_number] => 10042797
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/042797 | Catalyst for the production of olefin polymers | Jan 8, 2002 | Issued |
Array
(
[id] => 7622235
[patent_doc_number] => 06977266
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-12-20
[patent_title] => 'Pyridone derivatives having affinity for cannabinoid 2-type receptor'
[patent_app_type] => utility
[patent_app_number] => 10/250421
[patent_app_country] => US
[patent_app_date] => 2001-12-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 93587
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/977/06977266.pdf
[firstpage_image] =>[orig_patent_app_number] => 10250421
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/250421 | Pyridone derivatives having affinity for cannabinoid 2-type receptor | Dec 25, 2001 | Issued |
Array
(
[id] => 6541384
[patent_doc_number] => 20020193605
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-12-19
[patent_title] => 'New dihydropyridine derivatives'
[patent_app_type] => new
[patent_app_number] => 10/023813
[patent_app_country] => US
[patent_app_date] => 2001-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16688
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0193/20020193605.pdf
[firstpage_image] =>[orig_patent_app_number] => 10023813
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/023813 | Dihydropyridine derivatives | Dec 20, 2001 | Issued |
Array
(
[id] => 7281232
[patent_doc_number] => 20040063609
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-01
[patent_title] => 'Chiral scaffolds and their preparation'
[patent_app_type] => new
[patent_app_number] => 10/433989
[patent_app_country] => US
[patent_app_date] => 2003-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4141
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0063/20040063609.pdf
[firstpage_image] =>[orig_patent_app_number] => 10433989
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/433989 | Chiral scaffolds and their preparation | Dec 20, 2001 | Issued |
Array
(
[id] => 7281567
[patent_doc_number] => 20040063944
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-01
[patent_title] => 'Farnesyl transferase inhibiting 4-substituted quinoline and quinazoline derivatives'
[patent_app_type] => new
[patent_app_number] => 10/451902
[patent_app_country] => US
[patent_app_date] => 2003-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19301
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0063/20040063944.pdf
[firstpage_image] =>[orig_patent_app_number] => 10451902
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/451902 | Farnesyl transferase inhibiting 4-substituted quinoline and quinazoline derivatives | Dec 20, 2001 | Issued |
Array
(
[id] => 7281372
[patent_doc_number] => 20040063749
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-01
[patent_title] => 'Excitatory amino acid receptor antagonists'
[patent_app_type] => new
[patent_app_number] => 10/451820
[patent_app_country] => US
[patent_app_date] => 2003-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27261
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0063/20040063749.pdf
[firstpage_image] =>[orig_patent_app_number] => 10451820
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/451820 | Excitatory amino acid receptor antagonists | Dec 19, 2001 | Issued |
Array
(
[id] => 5859926
[patent_doc_number] => 20020123509
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-05
[patent_title] => 'Carboxylic acid amides, pharmaceutical compositions containing these compounds, their use and the preparation thereof'
[patent_app_type] => new
[patent_app_number] => 10/025426
[patent_app_country] => US
[patent_app_date] => 2001-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8867
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0123/20020123509.pdf
[firstpage_image] =>[orig_patent_app_number] => 10025426
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/025426 | Carboxylic acid amides, pharmaceutical compositions containing these compounds, their use and the preparation thereof | Dec 18, 2001 | Issued |
Array
(
[id] => 1528752
[patent_doc_number] => 06479660
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-11-12
[patent_title] => 'Process for the preparation of anti-malarial drugs'
[patent_app_type] => B1
[patent_app_number] => 09/051571
[patent_app_country] => US
[patent_app_date] => 2001-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5864
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/479/06479660.pdf
[firstpage_image] =>[orig_patent_app_number] => 09051571
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/051571 | Process for the preparation of anti-malarial drugs | Dec 13, 2001 | Issued |
Array
(
[id] => 6308231
[patent_doc_number] => 20020095039
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-07-18
[patent_title] => 'Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists'
[patent_app_type] => new
[patent_app_number] => 10/020780
[patent_app_country] => US
[patent_app_date] => 2001-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17290
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0095/20020095039.pdf
[firstpage_image] =>[orig_patent_app_number] => 10020780
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/020780 | Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists | Dec 13, 2001 | Abandoned |
| 10/023363 | Kinase inhibitors | Dec 12, 2001 | Abandoned |
Array
(
[id] => 1389435
[patent_doc_number] => 06548548
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-04-15
[patent_title] => 'ABCA-1 elevating compounds'
[patent_app_type] => B2
[patent_app_number] => 10/010602
[patent_app_country] => US
[patent_app_date] => 2001-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13212
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/548/06548548.pdf
[firstpage_image] =>[orig_patent_app_number] => 10010602
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/010602 | ABCA-1 elevating compounds | Dec 5, 2001 | Issued |
Array
(
[id] => 6132075
[patent_doc_number] => 20020077481
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-06-20
[patent_title] => 'Process for the preparation of mixed anhydrides'
[patent_app_type] => new
[patent_app_number] => 10/008981
[patent_app_country] => US
[patent_app_date] => 2001-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6029
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20020077481.pdf
[firstpage_image] =>[orig_patent_app_number] => 10008981
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/008981 | Process for the preparation of mixed anhydrides | Dec 5, 2001 | Issued |
Array
(
[id] => 6082628
[patent_doc_number] => 20020082274
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-06-27
[patent_title] => 'Preparation of sodium-hydrogen exchanger type-1 inhibitors'
[patent_app_type] => new
[patent_app_number] => 09/995133
[patent_app_country] => US
[patent_app_date] => 2001-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11218
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20020082274.pdf
[firstpage_image] =>[orig_patent_app_number] => 09995133
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/995133 | Preparation of sodium-hydrogen exchanger type-1 inhibitors | Nov 26, 2001 | Issued |
Array
(
[id] => 5829462
[patent_doc_number] => 20020068827
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-06-06
[patent_title] => 'Quinoline-4-carboxamide derivatives, their preparation and their use as neurokinin 3 ( NK-3 ) - and neurokinin 2 ( NK-3 ) receptor antagonists'
[patent_app_type] => new
[patent_app_number] => 09/994402
[patent_app_country] => US
[patent_app_date] => 2001-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26618
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0068/20020068827.pdf
[firstpage_image] =>[orig_patent_app_number] => 09994402
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/994402 | Quinoline-4-carboxamide derivatives, their preparation and their use as neurokinin 3 ( NK-3 ) - and neurokinin 2 ( NK-3 ) receptor antagonists | Nov 25, 2001 | Abandoned |
Array
(
[id] => 6544340
[patent_doc_number] => 20020137664
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-26
[patent_title] => 'Substituted piperidines as melanocortin-4 receptor agonists'
[patent_app_type] => new
[patent_app_number] => 09/990499
[patent_app_country] => US
[patent_app_date] => 2001-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23231
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20020137664.pdf
[firstpage_image] =>[orig_patent_app_number] => 09990499
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/990499 | Substituted piperidines as melanocortin-4 receptor agonists | Nov 20, 2001 | Abandoned |
Array
(
[id] => 1521174
[patent_doc_number] => 06413985
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-07-02
[patent_title] => 'Tetrahydroquinoline derivatives as glycine antagonists'
[patent_app_type] => B1
[patent_app_number] => 09/990513
[patent_app_country] => US
[patent_app_date] => 2001-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20191
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/413/06413985.pdf
[firstpage_image] =>[orig_patent_app_number] => 09990513
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/990513 | Tetrahydroquinoline derivatives as glycine antagonists | Nov 15, 2001 | Issued |
Array
(
[id] => 6555905
[patent_doc_number] => 20020111492
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-15
[patent_title] => 'Heterocyclylalkylpiperidine derivatives, their preparation and compositions containing them'
[patent_app_type] => new
[patent_app_number] => 09/987386
[patent_app_country] => US
[patent_app_date] => 2001-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 133014
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0111/20020111492.pdf
[firstpage_image] =>[orig_patent_app_number] => 09987386
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/987386 | Heterocyclylalkylpiperidine derivatives, their preparation and compositions containing them | Nov 13, 2001 | Issued |
Array
(
[id] => 1093549
[patent_doc_number] => 06825354
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-11-30
[patent_title] => 'Alkynyl containing hydroxamic acid compounds as matrix metalloproteinase and TACE inhibitors'
[patent_app_type] => B2
[patent_app_number] => 10/055502
[patent_app_country] => US
[patent_app_date] => 2001-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29873
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 330
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/825/06825354.pdf
[firstpage_image] =>[orig_patent_app_number] => 10055502
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/055502 | Alkynyl containing hydroxamic acid compounds as matrix metalloproteinase and TACE inhibitors | Nov 12, 2001 | Issued |
Array
(
[id] => 1206003
[patent_doc_number] => 06716856
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-04-06
[patent_title] => '4,5,6,7-tetrahydroindazole derivatives as antitumor agents'
[patent_app_type] => B1
[patent_app_number] => 09/926478
[patent_app_country] => US
[patent_app_date] => 2001-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29946
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 387
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/716/06716856.pdf
[firstpage_image] =>[orig_patent_app_number] => 09926478
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/926478 | 4,5,6,7-tetrahydroindazole derivatives as antitumor agents | Nov 8, 2001 | Issued |
Array
(
[id] => 6409983
[patent_doc_number] => 20020038033
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-03-28
[patent_title] => 'Methods for the preparation of intermediates in the synthesis of HIV-protease inhibitors'
[patent_app_type] => new
[patent_app_number] => 09/986146
[patent_app_country] => US
[patent_app_date] => 2001-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10518
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0038/20020038033.pdf
[firstpage_image] =>[orig_patent_app_number] => 09986146
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/986146 | Methods for the preparation of intermediates in the synthesis of HIV-protease inhibitors | Nov 6, 2001 | Issued |